5-Amino-1MQ vs Dulaglutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ metabolism and energy expenditure in adipose tissue. By blocking NNMT, 5-Amino-1MQ raises intracellular NAD+ and SAM levels, pushing stem cells toward muscle and bo...
Calculate 5-Amino-1MQ dose →Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...
Calculate Dulaglutide dose →| Parameter | 5-Amino-1MQ | Dulaglutide |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | FDA Approved |
| Half-Life | ~4 hours (estimated) | ~5 days |
| Typical Dose | 50 mg | 0.75–4.5 mg |
| Frequency | Once daily | Once weekly |
| Route | Oral | Subcutaneous (weekly) |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.